Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: Population-based cohort study with 6-year follow-up

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Mäntyselkä, Pekka ^a,b   Niskanen, Leo ^a,c   Kautiainen, Hannu ^b,d   Saltevo, Juha ^e   Würtz, Peter ^d,f   Soininen, Pasi ^a,f   Kangas, Antti J ^a,f   Ala Korpela, Mika ^a,f,g,h   Vanhala, Mauno ^a,e  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Finnish Medicines Agency Fimea   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF OULU   (Finland)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

^h OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cohort study; Fatty acid; Lipoprotein profile

Indexed keywords

ADULT; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; PARTICLE SIZE; TREATMENT OUTCOME;

EID: 84893649097     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-28     Document Type: Article

References (22)

1. Dietary omega-3 polyunsaturated fatty acid intake is related to a protective high-density lipoprotein subspecies profile independent of genetic effects: a monozygotic twin pair study. Bogl LH, Maranghi M, Rissanen A, Kaprio J, Taskinen MR, Pietiläinen KH, Atherosclerosis 2011 219 880 886 10.1016/j.atherosclerosis.2011.09.010 21962401
2. Association between habitual dietary intake and lipoprotein subclass profile in healthy young adults. Bogl LH, Pietiläinen KH, Rissanen A, Kangas AJ, Soininen P, Rose RJ, et al. Nutr Metab Cardiovasc Dis 2013 doi:10.1016/j.numecd.2012.11.007
3. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, ORIGIN Trial Investigators, et al. N Engl J Med 2012 367 309 318 22686415
4. n-3 fatty acids in patients with multiple cardiovascular risk factors. Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Risk and Prevention Study Collaborative Group, et al. N Engl J Med 2013 368 1800 1808 23656645
5. Omega-3 fatty acid blood levels: clinical significance and controversy. Superko HR, Superko SM, Nasir K, Agatston A, Garrett BC, Circulation 2013 128 2154 2161 10.1161/CIRCULATIONAHA.113.002731 24190935
6. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, et al. Circulation 2009 119 902 907 10.1161/CIRCULATIONAHA.108.191627 19171857
7. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, et al. BMJ 2013 346 8707 10.1136/bmj.e8707 23386268
8. Association of serum n-6 and n-3 polyunsaturated fatty acids with lipids in 3 populations of middle-aged men. Motoyama KR, Curb JD, Kadowaki T, El-Saed A, Abbott RD, Okamura T, et al. Am J Clin Nutr 2009 90 49 55 10.3945/ajcn.2008.26761 19474136
9. Serum n-6 fatty acids and lipoprotein subclasses in middle-aged men: the population-based cross-sectional ERA-JUMP study. Choo J, Ueshima H, Curb JD, Shin C, Evans RW, El-Saed A, ERA-JUMP Study Group, et al. Am J Clin Nutr 2010 91 1195 1203 10.3945/ajcn.2009.28500 20357040
10. Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study. Vanhala M, Saltevo J, Soininen P, Kautiainen H, Kangas AJ, Ala-Korpela M, et al. Am J Epidemiol 2012 176 253 260 10.1093/aje/kwr504 22791741
11. Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men. Wang J, Stančáková A, Soininen P, Kangas AJ, Paananen J, Kuusisto J, et al. J Intern Med 2012 272 562 572 10.1111/j.1365-2796.2012.02562.x 22650159
12. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Soininen P, Kangas AJ, Würtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. Analyst 2009 134 1781 1785 10.1039/b910205a 19684899
13. Metabonomic, transcriptomic, and genomic variation of a population cohort. Inouye M, Kettunen J, Soininen P, Silander K, Ripatti S, Kumpula LS, et al. Mol Syst Biol 2010 6 441 21179014
14. Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Ala-Korpela M, Clin Chem Lab Med 2008 46 27 42 18020967
15. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS). Ren J, Grundy SM, Liu J, Wang W, Wang M, Sun J, et al. Atherosclerosis 2010 211 327 32 10.1016/j.atherosclerosis.2010.02. 020 20223457
16. Low-density lipoprotein size and cardiovascular risk assessment. Rizzo M, Berneis K, QJM 2006 99 1 14 16371404 (Pubitemid 43124966)
17. Small dense LDL particles-a predictor of coronary artery disease evaluated by invasive and CT-based techniques: a case-control study. Toft-Petersen AP, Tilsted HH, Aarøe J, Rasmussen K, Christensen T, Griffin BA, et al. Lipids Health Dis 2011 10 21 10.1186/1476-511X-10-21 21262005
18. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial. Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, et al. Circulation 2006 113 1556e63
19. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, Tikkanen E, Lyytikäinen LP, et al. Nat Genet 2012 44 269 276 10.1038/ng.1073 22286219
20. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Laaksonen DE, Nyyssönen K, Niskanen L, Rissanen TH, Salonen JT, Arch Intern Med 2005 165 193 199 10.1001/archinte.165.2.193 15668366
21. Fetal growth, omega-3 (n-3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The Cardiovascular Risk in Young Finns Study. Skilton MR, Mikkilä V, Würtz P, Ala-Korpela M, Sim KA, Soininen P, et al. Am J Clin Nutr 2013 97 58 65 10.3945/ajcn.112.044198 23151534
22. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio Ischaemic Heart disease risk factor study. Rissanen T, Voutilainen S, Nyyssönen K, Lakka TA, Salonen JT, Circulation 2000 102 2677 2679 10.1161/01.CIR.102.22.2677 11094031